These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 24815844)

  • 21. Genetic polymorphisms of IL-1A, IL-1B, IL-1RN, NFKB1, FAS, and FASL, and risk of silicosis in a Chinese occupational population.
    Wu F; Xia Z; Qu Y; Tang Y; Cao D; Sun P; Christiani DC
    Am J Ind Med; 2008 Nov; 51(11):843-51. PubMed ID: 18666137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional polymorphisms in cell death pathway genes FAS and FAS ligand and risk of alopecia areata.
    Kalkan G; Ateş O; Karakuş N; Sezer S
    Arch Dermatol Res; 2013 Dec; 305(10):909-15. PubMed ID: 23591741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relation of the Fas and FasL gene polymorphisms with susceptibility to and severity of rheumatoid arthritis.
    Yıldır S; Sezgin M; Barlas IÖ; Türköz G; Ankaralı HÇ; Şahin G; Erdal ME
    Rheumatol Int; 2013 Oct; 33(10):2637-45. PubMed ID: 23749041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of apoptosis-related genes: Fas (CD94), FasL (CD178) and TRAIL polymorphisms in Iranian multiple sclerosis patients.
    Mohammadzadeh A; Pourfathollah AA; Sahraian MA; Behmanesh M; Daneshmandi S; Moeinfar Z; Heidari M
    J Neurol Sci; 2012 Jan; 312(1-2):166-9. PubMed ID: 21864851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FAS -670 A/G polymorphism may be associated with the depletion of CD4(+) T lymphocytes in HIV-1 infection.
    Hermes RB; Santana BB; Lima SS; Neris Martins Feitosa R; de Oliveira Guimarães Ishak M; Ishak R; Vallinoto AC
    Hum Immunol; 2015 Oct; 76(10):742-6. PubMed ID: 26429326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of promoter polymorphisms of Fas -FasL genes with development of Chronic Myeloid Leukemia.
    Edathara PM; Gorre M; Kagita S; Vuree S; Cingeetham A; Nanchari SR; Meka PB; Annamaneni S; Digumarthi RR; Satti V
    Tumour Biol; 2016 Apr; 37(4):5475-84. PubMed ID: 26563376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of chemokine and chemokine receptor gene variants on the susceptibility and clinicopathological characteristics of bladder cancer.
    Kucukgergin C; Isman FK; Dasdemir S; Cakmakoglu B; Sanli O; Gokkusu C; Seckin S
    Gene; 2012 Dec; 511(1):7-11. PubMed ID: 22982413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fas and Fas ligand gene polymorphisms in primary Sjögren's syndrome.
    Bolstad AI; Wargelius A; Nakken B; Haga HJ; Jonsson R
    J Rheumatol; 2000 Oct; 27(10):2397-405. PubMed ID: 11036836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphisms of extrinsic death receptor apoptotic genes (FAS -670 G>A, FASL -844 T>C) in coronary artery disease.
    Kishore Kumar G; Rajesh Kumar G; Mrudula Spurthi K; Nivas S; Chiranjeevi P; Ali A; Sahu SK; Pratibha N; Surekha Rani H
    Apoptosis; 2016 May; 21(5):558-65. PubMed ID: 26922070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Relationship between FAS/FASL gene polymorphisms and susceptibility of coal worker's pneumoconiosis].
    Ni CH; Song ZF; Jia XM; Li AP; Li CP; Li SK; Li YM; Wang ZL; Zhou Y; Wang SY; Zhang ZD; Zhou JW
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2007 Sep; 25(9):532-6. PubMed ID: 17997887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Importance of FAS-1377, FAS-670, and FASL-844 polymorphisms in tumor onset, progression, and pigment phenotypes of Swedish patients with melanoma: a case-control analysis.
    Zhang H; Sun XF; Synnerstad I; Rosdahl I
    Cancer J; 2007; 13(4):233-7. PubMed ID: 17762757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study of Fas (CD95) and FasL (CD178) polymorphisms in liver transplant recipients.
    Marín LA; Muro M; Moya-Quiles MR; Miras M; Minguela A; Bermejo J; Sanchez-Bueno F; Parrilla P; Alvarez-López MR
    Tissue Antigens; 2006 Feb; 67(2):117-26. PubMed ID: 16441482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma.
    Sun T; Miao X; Zhang X; Tan W; Xiong P; Lin D
    J Natl Cancer Inst; 2004 Jul; 96(13):1030-6. PubMed ID: 15240787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer.
    Park JY; Lee WK; Jung DK; Choi JE; Park TI; Lee EB; Cho S; Park JY; Cha SI; Kim CH; Kam S; Jung TH; Jheon S
    Clin Cancer Res; 2009 Mar; 15(5):1794-800. PubMed ID: 19240174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Fas/Fasl Gene Polymorphisms on Susceptibility Risk and Imatinib Mesylate Treatment Response in Chronic Myeloid Leukaemia Patients.
    Annuar AA; Ankathil R; Mohd Yunus N; Husin A; Ab Rajab NS; Abdul Aziz AA; Ibrahim MI; Sulong S
    Asian Pac J Cancer Prev; 2021 Feb; 22(2):565-571. PubMed ID: 33639675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fas and Fas ligand gene polymorphisms in Turkish patients with Familial Mediterranean Fever.
    Ozel EG; Duran GG; Celik MM; Duran N; Gunesacar R
    Gene; 2017 Aug; 623():29-32. PubMed ID: 28442396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of genetic variants in apoptosis genes FAS and FASL with radiation-induced late toxicity after prostate cancer radiotherapy.
    Thurner EM; Krenn-Pilko S; Langsenlehner U; Renner W; Gerger A; Kapp KS; Langsenlehner T
    Strahlenther Onkol; 2014 Mar; 190(3):304-9. PubMed ID: 24424626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional polymorphisms in apoptosis pathway genes and survival in patients with gastric cancer.
    Gu D; Du M; Tang C; Chu H; Xu Z; Huo X; Gong W; Tang Y; Zhou J; Tong N; Xu Y; Zhang Z; Wang M; Chen J
    Environ Mol Mutagen; 2014 Jun; 55(5):421-7. PubMed ID: 24535941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of BCL2 (ala43thr), CCND1 (G870A) and FAS (A-670G) polymorphisms in modulating the risk of developing esophageal cancer.
    Jain M; Kumar S; Lal P; Tiwari A; Ghoshal UC; Mittal B
    Cancer Detect Prev; 2007; 31(3):225-32. PubMed ID: 17561354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Associations between the FAS -670 A/G, -1377 G/A, and FASL -844 T/C polymorphisms and susceptibility to systemic lupus erythematosus: a meta-analysis.
    Lee YH; Song GG
    Clin Exp Rheumatol; 2016; 34(4):634-40. PubMed ID: 27050822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.